Nectar Lifesciences Ltd Declares Unaudited Q1 FY27 Results

Nectar Lifesciences Limited announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The board also approved the appointment of Dr. Gunmala Suri as an Additional Director and Non-Executive Non-Independent Director, subject to member approval. The 31st Annual General Meeting (AGM) is scheduled for September 18, 2026, with the register of members closing from September 12 to September 18, 2026. The re-appointment of Mr. Sanjiv Goyal was also noted. Committee compositions for Audit, SRC, and CSR were reconstituted.